{"entity":{"id":"haematologica","kind":"journal","name":"Haematologica","aka":["Haematologica"],"tldr":"The European Hematology Association's open-access journal, publishing haematological malignancy research from Europe and worldwide with no paywall.","summary":"Haematologica is the fully open-access journal of the European Hematology Association (EHA), founded in 1920 and published by the non-profit Ferrata Storti Foundation in Pavia on behalf of the society, with no paywall. It publishes clinical and translational studies in leukaemia, lymphoma, myeloma and MDS from Europe and worldwide, together with EHA guidelines and the EHA congress abstract book. Its readers are haematologists and researchers in haematological malignancy who want European society guidance and congress abstracts freely available. A reader of OnCo would use it for EHA guidelines and for open-access blood cancer research that can be read without a subscription.","asOf":"2026-09-09","links":[{"label":"European Hematology Association","url":"https://ehaweb.org"}],"tags":[],"related":[],"cancers":[],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"publisher":"Ferrata Storti Foundation","url":"https://haematologica.org","issn":"0390-6078","scope":"haematology","access":"open-access","founded":1920,"matchNames":["Haematologica"],"society":"European Hematology Association"},"route":"/journals/haematologica/","neighbours":{"cancer":[{"id":"aml","kind":"cancer","name":"Acute myeloid leukaemia","route":"/cancers/aml/"},{"id":"cll","kind":"cancer","name":"Chronic lymphocytic leukaemia","route":"/cancers/cll/"},{"id":"dlbcl","kind":"cancer","name":"Diffuse large B-cell lymphoma","route":"/cancers/dlbcl/"},{"id":"multiple-myeloma","kind":"cancer","name":"Multiple myeloma","route":"/cancers/multiple-myeloma/"}],"person":[{"id":"antonio-cuneo","kind":"person","name":"Antonio Cuneo","route":"/people/antonio-cuneo/"},{"id":"jurgen-kuball","kind":"person","name":"Jürgen Kuball","route":"/people/jurgen-kuball/"},{"id":"nicolaas-schaap","kind":"person","name":"Nicolaas P.M. Schaap","route":"/people/nicolaas-schaap/"},{"id":"richard-van-etten","kind":"person","name":"Richard Van Etten","route":"/people/richard-van-etten/"},{"id":"sirpa-leppa","kind":"person","name":"Sirpa Leppä","route":"/people/sirpa-leppa/"},{"id":"steven-le-gouill","kind":"person","name":"Steven Le Gouill","route":"/people/steven-le-gouill/"}],"institution":[{"id":"eha","kind":"institution","name":"European Hematology Association","route":"/institutions/eha/"}],"paper":[{"id":"paper-aaml1031-bortezomib-aplenc-haematologica-2020","kind":"paper","name":"AAML1031: bortezomib with standard chemotherapy for children with acute myeloid leukaemia does not improve outcomes","route":"/key-papers/paper-aaml1031-bortezomib-aplenc-haematologica-2020/"},{"id":"paper-nxc-201-hbi0101-asherie-haematologica-2023","kind":"paper","name":"Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial (HBI0101)","route":"/key-papers/paper-nxc-201-hbi0101-asherie-haematologica-2023/"}]}}